Shire sues US firm over epilepsy drug
Thursday 15 January 2004
Shire Pharmaceuticals has launched a lawsuit against Nostrum Pharmaceuticals after it made public plans to launch a similar version of Shire's epilepsy drug Carbatrol.
Nostrum, a privately owned company based in New Jersey, filed a new drug application for a generic version of the 300mg dosage strength of Carbatrol.
Shire, which launched its Carbatrol drug in 1998, said it had served Nostrum with a complaint for patent infringement but would not go into details. A spokeswoman said its patents on the drug - which has made about $164m of sales since its launch - did not expire until 2016. "Our lawyers have looked at the dossier [from Nostrum that has been filed with the US Food & Drug Administration] and believe it infringes patents," she said.
The move is not a great surprise, however, since the FDA announced last summer that an unnamed drug manufacturer had asked it to approve a copycat version of Shire's epilepsy treatment.
Carbatrol is one of Shire's main drugs and produced sales of $11.6m in the third quarter of last year. The company estimates it has about a 40 per cent market share.
The spokeswoman also said yesterday that the filing centred only on the 300mg strength of the drug and did not affect its 100mg or its 200mg products.
The 300mg strength, she said, made up about half the total sales Shire has so far recorded from Carbatrol.
The company's response to Nostrum's filing triggers a 30-month stay of approval - meaning the earliest date a generic version of the drug could be launched, if cleared by the court, is January 2006.
Shire's biggest selling drug is its hyperactivity drug Adderall XR, which accounts for about half of its sales. It is also battling to prevent generic versions of that drug hitting the market. At the end of last year, it announced it was suing the US drug maker Impax, which signalled it was developing a copy of Adderall XR. It has already launched proceedings against Barr, another US company developing generic Adderall.
- 1 Isis 'jihadi bride' claims forced sex with Yazidi girls is never rape because Koran condones it
- 2 Woman accidentally shoots herself in the head while posing for a selfie
- 3 Art Garfunkel calls Paul Simon a 'monster' with a Napoleon complex
- 4 Isis burns woman alive for refusing to engage in 'extreme' sex act, UN says
- 5 Puerto Rico, island of lost dreams: People are leaving the debt-hit territory in droves as near neighbour Cuba's star rises
Isis 'jihadi bride' claims forced sex with Yazidi girls is never rape because Koran condones it
Woman accidentally shoots herself in the head while posing for a selfie
Isis burns woman alive for refusing to engage in 'extreme' sex act, UN says
Puerto Rico, island of lost dreams: People are leaving the debt-hit territory in droves as near neighbour Cuba's star rises
16-year-old girl beaten and burned alive by lynch mob in Rio Bravo, Guatemala
As a white man, I'm surprised more women aren't tweeting the hashtag #KillAllWhiteMen
Scotland may have to leave the EU even if it votes to stay in, David Cameron confirms
The day that Britain resigned as a global power
Almost a third of school pupils believe 'Muslims are taking over our country', study claims
SNP fury as HS2 finds 'no business case' for taking fast train service to Scotland
Gay marriage 'Bert and Ernie' cake bakery found guilty of discrimination in Northern Ireland
iJobs Money & Business
£40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...
£45,000 - £55,000: Neil Pavier: Are you looking for your next opportunity for ...
£45,000 - £55,000: Sheridan Maine: Are you a newly qualified ACA/ACCA/ACMA qua...
£50,000 - £60,000: Laura Norton: Are you looking for an opportunity within a w...